Limb Immobilization for Muscle Atrophy
Trial Summary
What is the purpose of this trial?
This is an interventional study enrolling healthy individuals aged 18-35 and 60-85 to understand the recovery of muscle health following a period of inactivity. The enrollment goal is 45 participants. The study will occur over the course of 1-2 months where participants will undergo testing before and after a 2-week limb immobilization period.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but certain medications like anticoagulants and chronic systemic corticosteroids are not allowed. It's best to discuss your specific medications with the trial team.
What data supports the effectiveness of the treatment Limb immobilization, Splinting, Casting, Coaptation for muscle atrophy?
Is limb immobilization generally safe for humans?
Limb immobilization, such as casting and splinting, is generally safe but can have risks like stiffness, pressure sores, and compartment syndrome (a painful condition caused by pressure buildup). These risks are higher if the cast is applied by someone inexperienced, and certain groups, like young children or those with certain medical conditions, may be at higher risk for complications.678910
How does limb immobilization differ from other treatments for muscle atrophy?
Limb immobilization, such as casting or splinting, is unique because it physically restricts movement to induce muscle atrophy, which can be useful for studying the condition. Unlike other treatments that may focus on preventing atrophy, this method intentionally causes it to understand and manage muscle loss better.68111213
Research Team
Micah Drummond
Principal Investigator
University of Utah
Eligibility Criteria
Healthy individuals aged 18-35 and 60-85 can join this study on muscle health recovery after inactivity. Participants must be able to consent and live independently. Exclusions include a risk of blood clots, certain blood disorders, implanted electronic devices, recent steroid use, hormone treatments, pregnancy, staff under the investigator's supervision, or any condition deemed exclusionary by the lead researcher.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-testing
Participants undergo blood screening, oral glucose tolerance test, and receive a step activity monitor
Immobilization
Participants undergo a 2-week leg immobilization period
Recovery
Participants undergo testing including biopsy, blood draw, body composition scan, MRI, and muscle strength testing
Follow-up
Participants are monitored for recovery of muscle health after immobilization
Treatment Details
Interventions
- Limb immobilization
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor